These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 32043324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review.
    Arkoulis N, Mabvuure NT, Smith A, Barnes DE.
    J Plast Reconstr Aesthet Surg; 2021 Jun; 74(6):1402-1407. PubMed ID: 33388270
    [Abstract] [Full Text] [Related]

  • 4. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
    Singer AJ, McClain SA, Taira BR, Rooney J, Steinhauff N, Rosenberg L.
    J Burn Care Res; 2010 Jun; 31(2):304-9. PubMed ID: 20182376
    [Abstract] [Full Text] [Related]

  • 5. Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.
    Fischer S, Haug V, Diehm Y, Rhodius P, Cordts T, Schmidt VJ, Kotsougiani D, Horter J, Kneser U, Hirche C.
    Surgery; 2019 Jun; 165(6):1100-1105. PubMed ID: 30678870
    [Abstract] [Full Text] [Related]

  • 6. [Effects of early debridement and conservative eschar removal followed by wound coverage with acellular dermal matrix in the treatment of children with deep burns].
    Liang Y, Shi W, Shao Y, Liu XZ, Gong HM, Cao GH, Gao C, Xin NJ, Song GD.
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2024 Apr 20; 40(4):348-357. PubMed ID: 38664029
    [Abstract] [Full Text] [Related]

  • 7. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
    Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, Shoham Y, Singer AJ.
    Burns; 2014 May 20; 40(3):466-74. PubMed ID: 24074719
    [Abstract] [Full Text] [Related]

  • 8. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C, Kreken Almeland S, Dheansa B, Fuchs P, Governa M, Hoeksema H, Korzeniowski T, Lumenta DB, Marinescu S, Martinez-Mendez JR, Plock JA, Sander F, Ziegler B, Kneser U.
    Burns; 2020 Jun 20; 46(4):782-796. PubMed ID: 32241591
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of Bromelain-Based Enzymatic Debridement Combined with Laser Doppler Imaging and Healing of Burn Wounds.
    Korzeniowski T, Strużyna J, Torres K.
    Med Sci Monit; 2022 Aug 03; 28():e936713. PubMed ID: 35918878
    [Abstract] [Full Text] [Related]

  • 12. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
    Korzeniowski T, Strużyna J, Chrapusta AM, Krajewski A, Kucharzewski M, Piorun K, Nowakowski J, Surowiecka A, Kozicka M, Torres K.
    Med Sci Monit; 2022 Jan 22; 28():e935632. PubMed ID: 35064095
    [Abstract] [Full Text] [Related]

  • 13. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
    Ho W, Jones CD, Widdowson D, Bahia H.
    J Wound Care; 2019 Nov 02; 28(11):758-761. PubMed ID: 31721672
    [Abstract] [Full Text] [Related]

  • 14. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®.
    Sharaf A, Muthayya P.
    Burns; 2022 Nov 02; 48(7):1618-1625. PubMed ID: 34973852
    [Abstract] [Full Text] [Related]

  • 15. Selectivity of a bromelain based enzymatic debridement agent: a porcine study.
    Rosenberg L, Krieger Y, Silberstein E, Arnon O, Sinelnikov IA, Bogdanov-Berezovsky A, Singer AJ.
    Burns; 2012 Nov 02; 38(7):1035-40. PubMed ID: 22385643
    [Abstract] [Full Text] [Related]

  • 16. [REVIEW OF 30 YEARS OF RESEARCH AND DEVELOPMENT OF AN ENZYMATIC DEBRIDEMENT AGENT FOR BURNS].
    Krieger Y, Shoham Y, Bogdanov-Berezovsky A, Silberstein E, Sagi A, Levy A, Rosenberg N, Rubin G, Egozi D, Ullman Y, Haik J, Rosenberg L.
    Harefuah; 2016 May 02; 155(5):281-5, 323, 322. PubMed ID: 27526555
    [Abstract] [Full Text] [Related]

  • 17. Helpful hints in deciding what and when to operate after enzymatic debridement.
    Claes KEY, De Decker I, Monstrey S, Shoham Y, Vyncke T, Depypere B, De Wolf E, Decuypere F, Lannau B, Hoeksema H.
    Burns; 2023 Feb 02; 49(1):80-90. PubMed ID: 35177282
    [Abstract] [Full Text] [Related]

  • 18. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y, Gasteratos K, Singer AJ, Krieger Y, Silberstein E, Goverman J.
    Int Wound J; 2023 Dec 02; 20(10):4364-4383. PubMed ID: 37455553
    [Abstract] [Full Text] [Related]

  • 19. Assessing the Effect of Enzymatic Debridement on the Scar Quality in Partial-Thickness Burns to Deep Dermal Burns of the Hand: A Long-Term Evaluation.
    Heitzmann W, Schulz A, Fuchs PC, Schiefer JL.
    Medicina (Kaunas); 2024 Mar 14; 60(3):. PubMed ID: 38541207
    [Abstract] [Full Text] [Related]

  • 20. Enzymatic debridement of hands with deep burns: a single center experience in the treatment of 52 hands.
    Dadras M, Wagner JM, Wallner C, Sogorski A, Sacher M, Harati K, Lehnhardt M, Behr B.
    J Plast Surg Hand Surg; 2020 Aug 14; 54(4):220-224. PubMed ID: 32315252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.